Riskpilot← Back to searchSign inGet full accessTEMPELTERAPI AB
ABActiveOrg 5591569628Vallgravsgatan 3Medical specialists activities · NACE 8622Est. 20181 employees
Revenue 2025
SEK 602K
+167% vs 2024
EBITDA margin
27.5%
+26% vs 2024
Equity ratio
68.5%
Financial strength
Net profit 2025
SEK 131K
+25% vs 2024
| Revenue | SEK 602K | +167% |
| EBITDA | SEK 165K | +26% |
| Net profit | SEK 131K | +25% |
| Total assets | SEK 362K | +96% |
| Equity | SEK 248K | +49% |
| Employees | 1 | — |
Legal name
TEMPELTERAPI AB
Org number
5591569628
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
25 april 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bedriva läkarpraktik samt utbildning, konsultuppdrag, föredrag, rådgivning och terapi inom gynekologi, obstetrik, sexologi, uroterapi, mindfulness, tantra, funktionsmedicin, akupressur, personlig utveckling och därmed förenlig verksamhet. Importering och försäljning av hälsoprodukter. Äga och förvalta lös och fast egendom.
Address
Vallgravsgatan 3
Email
hildur.hadenius@icloud.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 139 | 43 | 118 | 225 | 602 |
| Staff expenses | — | −10 | −0 | −26 | −310 |
| EBITDA | 30 | −11 | 80 | 132 | 165 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 30 | −11 | 80 | 132 | 165 |
| Net financials | 74 | −0 | −127 | 0 | 0 |
| Profit before tax | 105 | −11 | −47 | 132 | 165 |
| Tax | −22 | — | −14 | −27 | −34 |
| Net profit | 83 | −11 | −61 | 105 | 131 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 227 | 127 | 137 | 185 | 362 |
| Equity | 184 | 124 | 62 | 167 | 248 |
| Long-term debt | 0 | — | 62 | 2 | 0 |
| Short-term debt | 42 | 3 | 13 | 16 | 114 |
| Total debt | 42 | 3 | 75 | 18 | 114 |
EBITDA margin
27.5%
This company
15.8%
Market median
+74% vs market
20212025
Equity ratio
68.5%
This company
38.2%
Market median
+79% vs market
20212025
Return on equity
52.9%
This company
18.4%
Market median
+188% vs market
20212025
Net profit margin
21.8%
This company
8.1%
Market median
+169% vs market
20212025
Asset turnover
1.66×
This company
1.12×
Market median
+48% vs market
20212025
Debt / equity
0.46×
This company
0.62×
Market median
+26% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TEMPELTERAPI AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl David Harald Hadenius | Deputy Board Member | 0 companies |
| Hildur Karin Ingrid Hadenius | Board of Directors | 0 companies |